Next Article in Journal
Electrical/Mechanical Monitoring of Shape Memory Alloy Reinforcing Fibers Obtained by Pullout Tests in SMA/Cement Composite Materials
Next Article in Special Issue
Highly-Bioreactive Silica-Based Mesoporous Bioactive Glasses Enriched with Gallium(III)
Previous Article in Journal
DFT Insights into the Role of Relative Positions of Fe and N Dopants on the Structure and Properties of TiO2
Previous Article in Special Issue
On the Potential of Bulk Metallic Glasses for Dental Implantology: Case Study on Ti40Zr10Cu36Pd14

Gentamicin-Releasing Mesoporous ZnO Structures

Department of Applied Science and Technology, Politecnico di Torino, Duca degli Abruzzi 24, 10129 Turin, Italy
Authors to whom correspondence should be addressed.
Materials 2018, 11(2), 314;
Received: 29 January 2018 / Revised: 11 February 2018 / Accepted: 17 February 2018 / Published: 22 February 2018
(This article belongs to the Special Issue Selected papers from EUROMAT 2017 Conference—Biomaterials)
Among metal oxides, zinc oxide (ZnO) is one of the most attractive materials thanks to its biocompatible and biodegradable properties along with the existence of various morphologies featuring piezoelectric, semiconducting and photocatalytic activities. All of these structures were successfully prepared and tested for numerous applications, including optoelectronics, sensors and biomedical ones. In the last case, biocompatible ZnO nanomaterials positively influenced cells growth and tissue regeneration as well, promoting wound healing and new bone formation. Despite showing high surface areas, ZnO morphologies generally lack an intrinsic mesoporous structure, strongly limiting the investigation of the corresponding drug loading and release properties. Within this scope, this study focuses on the adsorption and release properties of high surface area, mesoporous ZnO structures using gentamicin sulfate (GS), a well known antibiotic against bacterial infections especially in orthopedics. The particular ZnO morphology was achieved starting from sputtered porous zinc layers, finally converted into ZnO by thermal oxidation. By taking advantage of this mesoporous framework, GS was successfully adsorbed within the ZnO matrix and the kinetic release profile evaluated for up to seven days. The adsorption of GS was successfully demonstrated, with a maximum amount of 263 mg effectively loaded per gram of active material. Then, fast kinetic release was obtained in vitro by simple diffusion mechanism, thus opening further possibilities of smart pore and surface engineering to improve the controlled delivery. View Full-Text
Keywords: zinc oxide; mesoporous structure; gentamicin sulfate; drug delivery zinc oxide; mesoporous structure; gentamicin sulfate; drug delivery
Show Figures

Figure 1

MDPI and ACS Style

Laurenti, M.; Cauda, V. Gentamicin-Releasing Mesoporous ZnO Structures. Materials 2018, 11, 314.

AMA Style

Laurenti M, Cauda V. Gentamicin-Releasing Mesoporous ZnO Structures. Materials. 2018; 11(2):314.

Chicago/Turabian Style

Laurenti, Marco, and Valentina Cauda. 2018. "Gentamicin-Releasing Mesoporous ZnO Structures" Materials 11, no. 2: 314.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop